-
Something wrong with this record ?
Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism
G. Lombardi, NR. Jørgensen, NC. Harvey, EV. McCloskey, KE. Åkesson, R. Eastell, P. Garnero, JA. Kanis, P. Khashayar, NE. Lane, MR. McClung, S. Silverman, K. Makris, HP. Bhattoa, SD. Vasikaran, R. Pikner, E. Cavalier, Joint IOF Working Group and...
Language English Country Germany
Document type Journal Article, Guideline
- MeSH
- Biomarkers * metabolism analysis MeSH
- Bone and Bones * metabolism MeSH
- Humans MeSH
- Osteoporosis diagnosis metabolism MeSH
- Terminology as Topic * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Guideline MeSH
The presented guidelines are an update of the position paper, endorsed by the International Osteoporosis Foundation (IOF), on nomenclature of bone markers published over 2 decades ago. Novel insight into bone biology and pathophysiology of bone disorders has highlighted the increasing relevance of new and known mediators implicated in various aspects of bone metabolism. This updated guideline proposes the nomenclature Bone Status Indices (BSI) as the comprehensive classification rather than bone turnover markers, bone markers, metabolic markers of bone turnover or metabolic markers of bone turnover, that are currently in use for the implicated molecules. On behalf of the IFCC Committee on Bone Metabolism and the Joint IOF Working Group and IFCC Committee on Bone Metabolism, the authors propose standardized nomenclature, abbreviations and measurement units for the bone status indices.
Cedars Sinai Medical Center and Geffen School of Medicine UCLA Los Angeles CA USA
Centre for Metabolic Bone Diseases University of Sheffield Sheffield UK
Clinical Biochemistry Department KAT General Hospital Kifissia Athens Greece
Department of Clinical Biochemistry and Bone Metabolism Klatovska Hospital Klatovy Czech Republic
Department of Clinical Biochemistry Rigshospitalet Copenhagen Denmark
Department of Clinical Chemistry CIRM University of Liège CHU de Liège Belgium
Department of Laboratory Medicine Faculty of Medicine University of Debrecen Debrecen Hungary
Department of Medicine Division of Rheumatology U C Davis Health Sacramento CA USA
Department of Orthopaedics Skåne University Hospital Malmö Sweden
Faculty of Health Care Studies University of West Bohemia Pilsen Czech Republic
INSERM Unit 1033 Edouard Herriot Hospital Lyon France
International Institute for Biosensing University of Minnesota Minneapolis USA
Laboratory of Experimental Biochemistry IRCCS Ospedale Galeazzi Sant'Ambrogio Milan Italy
Mary McKillop Institute for Health Research Australian Catholic University Melbourne Australia
MRC Lifecourse Epidemiology Centre University of Southampton Southampton UK
Oregon Osteoporosis Center Portland OR USA
PathWest Laboratory Medicine Fiona Stanley Hospital Murdoch WA Australia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25009433
- 003
- CZ-PrNML
- 005
- 20250429135103.0
- 007
- ta
- 008
- 250415s2025 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/cclm-2024-1148 $2 doi
- 035 __
- $a (PubMed)39576737
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Lombardi, Giovanni $u Laboratory of Experimental Biochemistry, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy $u Department of Athletics, Strength and Conditioning, Poznań University of Physical Education, Poznań, Poland $1 https://orcid.org/000000028365985X
- 245 10
- $a Guidelines for the correct use of the nomenclature of biochemical indices of bone status: a position statement of the Joint IOF Working Group and IFCC Committee on Bone Metabolism / $c G. Lombardi, NR. Jørgensen, NC. Harvey, EV. McCloskey, KE. Åkesson, R. Eastell, P. Garnero, JA. Kanis, P. Khashayar, NE. Lane, MR. McClung, S. Silverman, K. Makris, HP. Bhattoa, SD. Vasikaran, R. Pikner, E. Cavalier, Joint IOF Working Group and IFCC Committee on Bone Metabolism
- 520 9_
- $a The presented guidelines are an update of the position paper, endorsed by the International Osteoporosis Foundation (IOF), on nomenclature of bone markers published over 2 decades ago. Novel insight into bone biology and pathophysiology of bone disorders has highlighted the increasing relevance of new and known mediators implicated in various aspects of bone metabolism. This updated guideline proposes the nomenclature Bone Status Indices (BSI) as the comprehensive classification rather than bone turnover markers, bone markers, metabolic markers of bone turnover or metabolic markers of bone turnover, that are currently in use for the implicated molecules. On behalf of the IFCC Committee on Bone Metabolism and the Joint IOF Working Group and IFCC Committee on Bone Metabolism, the authors propose standardized nomenclature, abbreviations and measurement units for the bone status indices.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kosti a kostní tkáň $x metabolismus $7 D001842
- 650 12
- $a terminologie jako téma $7 D009626
- 650 12
- $a biologické markery $x metabolismus $x analýza $7 D015415
- 650 _2
- $a osteoporóza $x diagnóza $x metabolismus $7 D010024
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice $7 D016431
- 700 1_
- $a Jørgensen, Niklas Rye $u Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark $u Faculty of Health and Medical Sciences, Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark $1 https://orcid.org/0000000196245210
- 700 1_
- $a Harvey, Nicholas C $u MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK $u NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK $1 https://orcid.org/0000000281942512
- 700 1_
- $a McCloskey, Eugene V $u Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK $u Mellanby Centre for Musculoskeletal Research, MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, University of Sheffield, Sheffield, UK $u Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK $1 https://orcid.org/0000000301778140
- 700 1_
- $a Åkesson, Kristina E $u Department of Clinical Sciences, Clinical and Molecular Osteoporosis Research Unit, Lund University, Malmö, Sweden $u Department of Orthopaedics, Skåne University Hospital, Malmö, Sweden $1 https://orcid.org/0000000330242804
- 700 1_
- $a Eastell, Richard $u Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK $1 https://orcid.org/0000000203233366
- 700 1_
- $a Garnero, Patrick $u INSERM Unit 1033, Edouard Herriot Hospital, Lyon, France $1 https://orcid.org/0000000309395099
- 700 1_
- $a Kanis, John A $u Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK $u Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia $1 https://orcid.org/0000000231294326
- 700 1_
- $a Khashayar, Patricia $u International Institute for Biosensing, University of Minnesota, Minneapolis, USA $1 https://orcid.org/0000000175258418 $7 ntk20241239062
- 700 1_
- $a Lane, Nancy E $u Department of Medicine, Division of Rheumatology, U.C. Davis Health, Sacramento, CA, USA
- 700 1_
- $a McClung, Michael R $u Mary McKillop Institute for Health Research, Australian Catholic University, Melbourne, Australia $u Oregon Osteoporosis Center, Portland, OR, USA $1 https://orcid.org/0000000278270778
- 700 1_
- $a Silverman, Stuart $u Cedars-Sinai Medical Center and Geffen School of Medicine UCLA, Los Angeles, CA, USA $1 https://orcid.org/0000000253131018
- 700 1_
- $a Makris, Konstantinos $u Clinical Biochemistry Department, KAT General Hospital, Kifissia, Athens, Greece $u Laboratory for the Research of Musculoskeletal System "Th. Garofalidis", School of Medicine, National and Kapodistrian, University of Athens, Athens, Greece $1 https://orcid.org/0000000278969028
- 700 1_
- $a Bhattoa, Harjit Pal $u Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000249090065
- 700 1_
- $a Vasikaran, Samuel D $u PathWest Laboratory Medicine, Fiona Stanley Hospital, Murdoch, WA, Australia $1 https://orcid.org/0000000208313031
- 700 1_
- $a Pikner, Richard $u Department of Clinical Biochemistry and Bone Metabolism, Klatovska Hospital, Klatovy, Czech Republic $u Department of Clinical Biochemistry and Haematology, Faculty of Medicine Pilsen, Charles University Prague, Pilsen, Czech Republic $u Faculty of Health Care Studies, University of West Bohemia, Pilsen, Czech Republic $1 https://orcid.org/0000000206338876
- 700 1_
- $a Cavalier, Etienne $u Department of Clinical Chemistry, CIRM, University of Liège, CHU de Liège, Belgium $1 https://orcid.org/0000000309472226
- 710 2_
- $a Joint IOF Working Group and IFCC Committee on Bone Metabolism
- 773 0_
- $w MED00010886 $t Clinical chemistry and laboratory medicine $x 1437-4331 $g Roč. 63, č. 4 (2025), s. 704-711
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39576737 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250415 $b ABA008
- 991 __
- $a 20250429135059 $b ABA008
- 999 __
- $a ok $b bmc $g 2311051 $s 1246514
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 63 $c 4 $d 704-711 $e 20241125 $i 1437-4331 $m Clinical chemistry and laboratory medicine $n Clin Chem Lab Med $x MED00010886
- LZP __
- $a Pubmed-20250415
